Related Experiment Video
Updated: Apr 19, 2026
11:20
Retinal Pigment Epithelium Transplantation in a Non-human Primate Model for Degenerative Retinal Diseases
Published on: June 14, 2021
4.6K
Retinal microglia: just bystander or target for therapy?
Marcus Karlstetter1, Rebecca Scholz1, Matt Rutar2
1Laboratory for Experimental Immunology of the Eye, Department of Ophthalmology, University of Cologne, Cologne, Germany.
Progress in Retinal and Eye Research
|December 6, 2014
Summary
Microglia, the brain's immune cells, are reactive in many retinal diseases. Modulating these cells offers a potential therapeutic target for treating vision-threatening conditions.
Area of Science:
- Neuroscience
- Immunology
- Ophthalmology
Background:
- Microglia are resident immune cells in the brain and retina, acting as crucial sensors of the microenvironment.
- Microglial reactivity is a common feature in various retinal degenerative and inflammatory diseases, including common and rare conditions.
- These diseases encompass age-related macular degeneration, diabetic retinopathy, glaucoma, uveitis, retinitis pigmentosa, and neurological disorders with ocular manifestations.
Purpose of the Study:
- To review the balanced function of microglia under normal retinal conditions through cell-cell interactions.
- To summarize microglial responses to diverse forms of retinal injury.
- To explore the role of microglia in retinal complement regulation and aging-related inflammation.
Main Methods:
- Review of existing literature on microglial function in retinal diseases.
- Analysis of evidence from animal models and human tissue studies.
- Synthesis of findings on microglial reactivity, complement regulation, and aging.
Main Results:
- Microglial reactivity is a consistent finding across a spectrum of retinal diseases.
- Microglia actively participate in local complement regulation within the retina.
- Microglial aging influences chronic inflammatory processes in the retina.
Conclusions:
- Microglia are not passive bystanders but active participants in retinal diseases.
- Targeting microglial function presents a promising therapeutic strategy for retinal degenerative and inflammatory conditions.
- Understanding microglial behavior is key to developing novel treatments for vision loss.
